FNDC5 and sarcopenia: In this case, irisin might provide a therapeutic choice for treating diseases caused by inactivity (which often is the case for older adults), including osteoporosis and sarcopenia, or it may be used as a useful biomarker for the assessment of bone and muscle health as suggested by Leustean et al. [85].